IdentificationGeneric Name(2R)-2-(4-chlorophenyl)-2-[4-(1H-pyrazol-4-yl)phenyl]ethanamineDrugBank Accession NumberDB07857BackgroundNot AvailableTypeSmall MoleculeGroupsExperimentalStructure


3DDownload MOLSDF3D-SDFPDBSMILESInChI


 Similar StructuresStructure for (2R)-2-(4-chlorophenyl)-2-[4-(1H-pyrazol-4-yl)phenyl]ethanamine (DB07857)× CloseWeightAverage: 297.782 Monoisotopic: 297.103275234 Chemical FormulaC17H16ClN3SynonymsNot AvailablePharmacologyIndicationNot AvailableReduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.See how  Build, train, & validate predictive machine-learning models with structured datasets.See howContraindications & Blackbox WarningsAvoid life-threatening adverse drug eventsImprove clinical decision support with information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Learn more  Avoid life-threatening adverse drug events & improve clinical decision support.Learn morePharmacodynamicsNot AvailableMechanism of actionTargetActionsOrganismUcAMP-dependent protein kinase catalytic subunit alphaNot AvailableHumansUcAMP-dependent protein kinase inhibitor alphaNot AvailableHumansAbsorptionNot AvailableVolume of distributionNot AvailableProtein bindingNot AvailableMetabolismNot AvailableRoute of eliminationNot AvailableHalf-lifeNot AvailableClearanceNot AvailableAdverse EffectsImprove decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.Learn more  Improve decision support & research outcomes with our structured adverse effects data.Learn moreToxicityNot AvailablePathwaysNot AvailablePharmacogenomic Effects/ADRs 


Not AvailableInteractionsDrug Interactions 


This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist. Not AvailableFood InteractionsNot AvailableCategoriesDrug CategoriesNot AvailableChemical TaxonomyProvided by ClassyfireDescriptionThis compound belongs to the class of organic compounds known as diphenylmethanes. These are compounds containing a diphenylmethane moiety, which consists of a methane wherein two hydrogen atoms are replaced by two phenyl groups.KingdomOrganic compoundsSuper ClassBenzenoidsClassBenzene and substituted derivativesSub ClassDiphenylmethanesDirect ParentDiphenylmethanesAlternative ParentsPhenylpyrazoles / Monocyclic monoterpenoids / Aromatic monoterpenoids / Chlorobenzenes / Aralkylamines / Aryl chlorides / Heteroaromatic compounds / Azacyclic compounds / Organopnictogen compounds / Organochlorides / Monoalkylamines / Hydrocarbon derivatives


 show 2 moreSubstituentsAmine / Aralkylamine / Aromatic heteromonocyclic compound / Aromatic monoterpenoid / Aryl chloride / Aryl halide / Azacycle / Azole / Chlorobenzene / Diphenylmethane / Halobenzene / Heteroaromatic compound / Hydrocarbon derivative / Monocyclic monoterpenoid / Monoterpenoid / Organic nitrogen compound / Organochloride / Organohalogen compound / Organoheterocyclic compound / Organonitrogen compound / Organopnictogen compound / P-cymene / Phenylpyrazole / Primary aliphatic amine / Primary amine / Pyrazole


 show 16 moreMolecular FrameworkAromatic heteromonocyclic compoundsExternal DescriptorsNot AvailableAffected organismsNot AvailableChemical IdentifiersUNIINot AvailableCAS numberNot AvailableInChI KeyHWVGILTYGZFGLR-QGZVFWFLSA-NInChIInChI=1S/C17H16ClN3/c18-16-7-5-14(6-8-16)17(9-19)13-3-1-12(2-4-13)15-10-20-21-11-15/h1-8,10-11,17H,9,19H2,(H,20,21)/t17-/m1/s1IUPAC Name(2R)-2-(4-chlorophenyl)-2-[4-(1H-pyrazol-4-yl)phenyl]ethan-1-amineSMILESNC[C@@H](C1=CC=C(Cl)C=C1)C1=CC=C(C=C1)C1=CNN=C1ReferencesGeneral ReferencesNot AvailableExternal LinksPubChem Compound15602983PubChem Substance99444328ChemSpider13078464BindingDB16220ChEMBLCHEMBL227924ZINCZINC000014960996PDBe LigandGVNPDB Entries2uw5Clinical TrialsClinical Trials 


PhaseStatusPurposeConditionsCountPharmacoeconomicsManufacturersNot AvailablePackagersNot AvailableDosage FormsNot AvailablePricesNot AvailablePatentsNot AvailablePropertiesStateSolidExperimental PropertiesNot AvailablePredicted PropertiesPropertyValueSourceWater Solubility0.00314 mg/mLALOGPSlogP3.74ALOGPSlogP3.44ChemaxonlogS-5ALOGPSpKa (Strongest Acidic)14.63ChemaxonpKa (Strongest Basic)9.68ChemaxonPhysiological Charge1ChemaxonHydrogen Acceptor Count2ChemaxonHydrogen Donor Count2ChemaxonPolar Surface Area54.7 Å2ChemaxonRotatable Bond Count4ChemaxonRefractivity87.48 m3·mol-1ChemaxonPolarizability32.23 Å3ChemaxonNumber of Rings3ChemaxonBioavailability1ChemaxonRule of FiveYesChemaxonGhose FilterYesChemaxonVeber's RuleNoChemaxonMDDR-like RuleNoChemaxonPredicted ADMET FeaturesPropertyValueProbabilityHuman Intestinal Absorption+1.0Blood Brain Barrier+0.972Caco-2 permeable+0.5359P-glycoprotein substrateNon-substrate0.7962P-glycoprotein inhibitor INon-inhibitor0.9531P-glycoprotein inhibitor IINon-inhibitor0.8089Renal organic cation transporterNon-inhibitor0.5549CYP450 2C9 substrateNon-substrate0.9095CYP450 2D6 substrateNon-substrate0.8409CYP450 3A4 substrateNon-substrate0.6872CYP450 1A2 substrateInhibitor0.8189CYP450 2C9 inhibitorNon-inhibitor0.6239CYP450 2D6 inhibitorNon-inhibitor0.825CYP450 2C19 inhibitorInhibitor0.656CYP450 3A4 inhibitorInhibitor0.5883CYP450 inhibitory promiscuityHigh CYP Inhibitory Promiscuity0.9122Ames testNon AMES toxic0.5618CarcinogenicityNon-carcinogens0.5252BiodegradationNot ready biodegradable1.0Rat acute toxicity2.5272 LD50, mol/kg Not applicablehERG inhibition (predictor I)Weak inhibitor0.9176hERG inhibition (predictor II)Non-inhibitor0.6058  ADMET data is predicted using admetSAR, a free tool for evaluating chemical ADMET properties. (23092397) SpectraMass Spec (NIST)Not AvailableSpectraSpectrumSpectrum TypeSplash KeyPredicted GC-MS Spectrum - GC-MSPredicted GC-MSNot AvailablePredicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSNot AvailableTargetsBuild, predict & validate machine-learning modelsUse our structured and evidence-based datasets to unlock newinsights and accelerate drug research.Learn more  Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.Learn more


 Details1. cAMP-dependent protein kinase catalytic subunit alphaKindProteinOrganismHumansPharmacological actionUnknownGeneral FunctionUbiquitin protein ligase bindingSpecific FunctionPhosphorylates a large number of substrates in the cytoplasm and the nucleus. Regulates the abundance of compartmentalized pools of its regulatory subunits through phosphorylation of PJA2 which bin...Gene NamePRKACAUniprot IDP17612Uniprot NamecAMP-dependent protein kinase catalytic subunit alphaMolecular Weight40589.38 DaReferencesBerman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [Article] 


 Details2. cAMP-dependent protein kinase inhibitor alphaKindProteinOrganismHumansPharmacological actionUnknownGeneral FunctionProtein kinase a catalytic subunit bindingSpecific FunctionExtremely potent competitive inhibitor of cAMP-dependent protein kinase activity, this protein interacts with the catalytic subunit of the enzyme after the cAMP-induced dissociation of its regulato...Gene NamePKIAUniprot IDP61925Uniprot NamecAMP-dependent protein kinase inhibitor alphaMolecular Weight7988.435 DaReferencesBerman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [Article] ×Identify potential medication risksEasily compare up to 40 drugs with our drug interaction checker.Get severity rating, description, and management advice. Learn more   Drug created at September 15, 2010 21:26 / Updated at June 12, 2020 16:52 